Skip to Main Content

Paper Details

Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection.
Alzheimers Dement
5
2023
APOE, APOE 4 allele, APOE), Alzheimer's Disease, Alzheimer's disease, Cognitive impairment, EOAD, amyloid, apolipoprotein E, apolipoprotein E (, cognitive impairment, non-Alzheimer's disease, participants
Author NameAffiliation
Laurel A BeckettUniversity of California - Davis
Tatiana ForoudIndiana University School of Medicine
Clifford R JackMayo Clinic
Joel H KramerUniversity of California - San Francisco
Robert A KoeppeUniversity of Michigan ann arbor
Malia RumbaughIndiana University School of Medicine
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Arthur W TogaUSC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine of USC
Ranjan DuaraWien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Neill R Graff-RadfordMayo Clinic
Lawrence S HonigTaub Institute and Department of Neurology, Columbia University Irving Medical Center
Kyle B WomackWashington University in St. Louis
Chiadi U OnyikeJohns Hopkins University School of Medicine
Stephen SallowayAlpert Medical School, Brown University
Raymond S TurnerGeorgetown University
Liana G ApostolovaIndiana University School of Medicine
Liana G ApostolovaIndiana University School of Medicine
Liana G ApostolovaCenter for Neuroimaging, Indiana University School of Medicine Indianapolis
  • 1 - 18

Datasets

Release 1.2